Proves de mutació gènica de cèl·lules de mamífers in vitro per a la investigació de toxicologia genètica

Paraules clau: TK gene mutation test, HGPRT gene mutation test, HPRT assay, thymidine kinase assay, in vitro mammalian cell gene mutation assay, OECD TG 476, OECD TG 490, genotoxicity testing, genetic toxicology, mutation assay, drug safety evaluation

Productes IPHASE

Introducció

In vitro mammalian cell gene mutation testing is an important approach in genetic toxicology for evaluating the mutagenic potential of chemical substances. Dos dels sistemes d'assaig més utilitzats en aquest camp són eltimidina quinasa (TK) gene mutation test and theHGPRT gene mutation test. These assays are commonly used because they provide a biologically relevant mammalian cell-based model for detecting mutation events under controlled experimental conditions. OECD Test Guideline 490 covers TK-based mammalian cell gene mutation testing, while OECD Test Guideline 476 covers in vitro mammalian cell gene mutation tests using theHprt ixprt gens.

As drug development, chemical safety assessment, and preclinical screening continue to demand reliable genotoxicity tools, these gene mutation assays remain essential in early-stage safety evaluation. Ajuden els investigadors a identificar compostos amb una possible responsabilitat mutagènica abans que els candidats avancen en el desenvolupament.

TK Gene Mutation Assay and OECD TG 490

The TK gene mutation assay is a standardized mammalian cell mutation test described in OECD TG 490. The guideline includes two validated assay systems that use TK-heterozygous cell lines: L5178Y tk+/− 3.7.2C mouse lymphoma cells and TK6 tk+/− human lymphoblastoid cells. Aquests sistemes s'utilitzen àmpliament perquè proporcionen un marc reproduïble per identificar mutacions gèniques induïdes per substàncies químiques.

Un dels punts forts de l'assaig TK és la seva capacitat per detectar tant mutacions gèniques com esdeveniments cromosòmics al locus TK. This gives researchers a broader view of the genetic effects of a test compound and makes the assay especially valuable in genetic toxicology, pharmaceutical screening, and nonclinical safety assessment.

HGPRT Gene Mutation Assay and OECD TG 476

L'assaig de mutació del gen HGPRT és un altre sistema establert de mutació de cèl·lules de mamífers in vitro utilitzat en toxicologia genètica. A l'OCDE TG 476, el mètode estandarditzat es descriu com ain vitro mammalian cell gene mutation test using the Hprt and Xprt genes, que és el marc associat habitualment a les proves de mutació basades en HGPRT/HPRT-. The guideline was originally adopted to support chemical mutation testing in mammalian cells and remains a widely recognized reference in genotoxicity research.

En termes pràctics, l'assaig HGPRT/HPRT s'utilitza per identificar mutacions que afecten la funció de la via de salvament de purines a les cèl·lules de mamífer. Because of its long history in genetic toxicology, it remains a useful tool for assessing mutagenic potential, comparing compound effects, and supporting early safety decisions in drug discovery and chemical screening workflows.

Antecedents científics

Both TK and HGPRT assays are based on the same core concept: after exposure to a test substance, mutant cells with altered gene function can be selected and analyzed to determine whether the compound has induced mutational events. These assays are valuable because they are performed in mammalian cells, which makes them more biologically relevant than simpler non-mammalian screening systems.

From a research perspective, these assays help scientists study how chemical exposure affects DNA integrity, mutation pathways, and cellular repair mechanisms. Per tant, s'utilitzen àmpliament en l'elaboració de perfils de compostos, desenvolupament d'assaigs i programes de toxicologia més amplis.

Aplicacions

La prova de mutació del gen TK i la prova de mutació del gen HGPRT s'utilitzen habitualment en el cribratge de genotoxicitat durant el descobriment precoç de fàrmacs. At this stage, researchers need to quickly identify compounds with potential mutagenic risks so they can make informed decisions before investing in later development work. El TG 490 de l'OCDE i el TG 476 de l'OCDE proporcionen marcs estandarditzats que donen suport a aquest tipus d'avaluació primerenca de seguretat.

Aquests assajos també s'utilitzen àmpliament en la investigació de toxicologia preclínica i l'avaluació de la seguretat dels compostos. In these settings, they can contribute important evidence about whether a substance may induce mutations in mammalian cells under controlled experimental conditions. Because both methods are long-established and internationally recognized, they are often included as part of a broader genotoxicity testing strategy.

A més, els sistemes basats en TK i HGPRT- són útils en el desenvolupament d'assaigs i l'optimització de mètodes. Laboratories often rely on these tests to establish experimental conditions, improve reproducibility, and generate consistent data across repeated runs. For teams that need a practical and repeatable solution, kit-based mammalian cell gene mutation testing can streamline workflow setup and routine screening.

For laboratories looking for a convenient research format, IPHASE In Vitro Mammalian Cell Gene Mutation Test (TK) and IPHASE In Vitro Mammalian Cell Gene Mutation Test (HGPRT) are both supplied in a 20 mL × 36 tests specification, supporting repeated use in routine testing and assay development.

Conclusió

Les proves de mutació gènica de cèl·lules de mamífers in vitro segueixen sent una eina bàsica en la investigació de toxicologia genètica. The TK assay and the HGPRT/HPRT assay each provide a standardized mammalian cell platform for evaluating mutagenic potential and supporting early safety assessment. OECD TG 490 and OECD TG 476 offer internationally recognized frameworks for these methods, helping laboratories generate reproducible and comparable data.

For laboratories involved in genotoxicity screening, compound safety evaluation, and preclinical toxicology research, IPHASE In Vitro Mammalian Cell Gene Mutation Test (TK) and IPHASE In Vitro Mammalian Cell Gene Mutation Test (HGPRT) provide practical solutions for supporting routine mammalian cell mutation studies.

Preguntes freqüents

What is the difference between the TK and HGPRT assays?
The TK assay evaluates mutations at the thymidine kinase locus and is covered by OECD TG 490, while the HGPRT/HPRT assay is associated with OECD TG 476, which covers Hprt/Xprt-based mammalian cell gene mutation testing.

Per què són importants aquests assajos en toxicologia genètica?
They are important because they help identify whether a chemical substance may induce gene mutations in mammalian cells, making them valuable tools for early safety screening and preclinical evaluation.

Which assay should a laboratory choose?
Això depèn del disseny de l'estudi, del flux de treball històric i del marc regulador o de recerca preferit. Els assajos basats en TK i els basats en HGPRT/HPRT són opcions ben establertes en les proves de mutació gènica de cèl·lules de mamífers.